Supernus Pharmaceuticals Inc (SUPN)

Inventory turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Cost of revenue (ttm)	US$ in thousands	401,888	295,781	310,746	314,799	321,031	418,757	454,848	468,008	467,442	489,145	440,870	414,500	382,420	340,324	326,355	288,181	258,697	221,602	190,722	179,160
Inventory	US$ in thousands	54,293	63,981	68,155	75,079	77,408	83,480	90,560	91,147	91,541	83,165	84,860	88,795	85,959	60,155	58,391	50,226	48,325	42,465	35,338	24,418
Inventory turnover		7.40	4.62	4.56	4.19	4.15	5.02	5.02	5.13	5.11	5.88	5.20	4.67	4.45	5.66	5.59	5.74	5.35	5.22	5.40	7.34

December 31, 2024 calculation

Inventory turnover = Cost of revenue (ttm) ÷ Inventory
= $401,888K ÷ $54,293K
= 7.40

Supernus Pharmaceuticals Inc's inventory turnover has fluctuated over the years based on the provided data. Inventory turnover is a financial ratio that indicates how many times a company's inventory is sold and replaced over a certain period. A higher inventory turnover generally signifies efficient inventory management.

In the case of Supernus Pharmaceuticals Inc, the inventory turnover ratio ranged from a low of 4.15 on December 31, 2023, to a high of 7.40 on December 31, 2024. The company experienced a gradual decrease in inventory turnover from 2020 to 2022, reaching a low point of 4.45 on December 31, 2021. Subsequently, the inventory turnover ratio began to increase again, reaching 7.40 on December 31, 2024.

The variations in Supernus Pharmaceuticals Inc's inventory turnover could be attributed to factors such as changes in demand for its products, seasonal fluctuations, or shifts in inventory management practices. It is important for the company to monitor its inventory turnover to ensure optimal utilization of resources and efficient operations.